Company Filing History:
Years Active: 1992
Title: Anke Schink: Innovator in Pharmaceutical Chemistry
Introduction
Anke Schink is a notable inventor based in Grasbrunn, Germany. She has made significant contributions to the field of pharmaceutical chemistry, particularly through her innovative work on p-Oxybenzoic acid derivatives. Her research has implications for drug development, especially in the area of hypolipemic action.
Latest Patents
Anke Schink holds a patent for p-Oxybenzoic acid derivatives, which includes a process for their preparation. The patent details the general formula for these derivatives and highlights their physiologically compatible salts, as well as their enantiomeric and diastereomeric forms. These compounds have been identified to possess hypolipemic properties, making them suitable for the formulation of drugs aimed at lowering lipid levels in the body.
Career Highlights
Anke Schink is currently employed at Klinge Pharma GmbH, where she continues to advance her research in pharmaceutical innovations. Her work has not only contributed to the scientific community but also to the development of effective therapeutic agents.
Collaborations
Anke has collaborated with esteemed colleagues such as Friedemann Reiter and Peter Jank, further enhancing the impact of her research through teamwork and shared expertise.
Conclusion
Anke Schink's contributions to pharmaceutical chemistry, particularly through her patent on p-Oxybenzoic acid derivatives, underscore her role as an influential inventor in the field. Her ongoing work at Klinge Pharma GmbH continues to pave the way for advancements in drug development.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.